Testes Talk: Matt Wakefield

CACTI
CACTI
Dec 12, 2018 · 2 min read
Image for post
Image for post

Meet Matt Wakefield, a 38-year-old barista from England and a two-time testicular cancer survivor.

At the young age of 20, Matt discovered a lump by chance. He says, “My knowledge of it was zero and I was embarrassed to come forward about it.” So after nine months of ignoring it, what started as the size of a finger nail grew to the size of his index and middle fingers put together. After seeing a doctor, he was diagnosed with a stage one seminoma, for which he had to undergo an orchidectomy and radiotherapy.

Unfortunately, his testicular cancer journey didn’t end there.

Fourteen years later, at the age of 34, Matt found another lump on his remaining testicle during a routine, weekly examination. He discovered the lump on a Friday night and was in the doctor’s office first thing Monday morning. The urologist said it was the smallest lump he has ever found. Just like the first, it was diagnosed as a stage one seminoma. He had an orchidectomy, radiotherapy and one round of chemotherapy (carboplatin).

As a result of his testicular cancer treatments, Matt is now dependent on hormone replacement therapy (HRT) for his body’s testosterone, which is in the form of an injection (Nebido) every ten weeks.

His advice to other men is, “You have zero control over what life throws at you, but you have every control over your attitude towards it. Don’t let a moment of embarrassment cost you a lifetime.”

Matt’s story highlights the importance of not only self-check, but of speaking up. There can be a stigma attached to talking about testicular cancer — and there shouldn’t be. That’s why it’s so important to spread awareness, educate and get the conversation going. Matt, thank you so much for sharing your story. Follow Matt on Instagram at @insta_flatbagger or Twitter at @xmas_flatbagger.

If you have any questions, feel free to comment or DM us. For resources on testicular cancer, please visit: cacti.org/resources/.

Testes Talks

Welcome to our #TestesTalk series, where we hear and share…

CACTI

Written by

CACTI

Center for Advocacy for Cancer of the Testes Int'l's mission is to advance the practice, research & education in the field of testes cancer. www.cacti.org

Testes Talks

Welcome to our #TestesTalk series, where we hear and share first-hand stories from those affected by testicular cancer. Each cancer journey is unique — from diagnosis to treatment and survivorship. ‘Meet’ some incredible people that we’ve had the privilege of speaking with.

CACTI

Written by

CACTI

Center for Advocacy for Cancer of the Testes Int'l's mission is to advance the practice, research & education in the field of testes cancer. www.cacti.org

Testes Talks

Welcome to our #TestesTalk series, where we hear and share first-hand stories from those affected by testicular cancer. Each cancer journey is unique — from diagnosis to treatment and survivorship. ‘Meet’ some incredible people that we’ve had the privilege of speaking with.

Medium is an open platform where 170 million readers come to find insightful and dynamic thinking. Here, expert and undiscovered voices alike dive into the heart of any topic and bring new ideas to the surface. Learn more

Follow the writers, publications, and topics that matter to you, and you’ll see them on your homepage and in your inbox. Explore

If you have a story to tell, knowledge to share, or a perspective to offer — welcome home. It’s easy and free to post your thinking on any topic. Write on Medium

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store